Island Granted FDA Orphan Drug Designation For Galidesivir In Marburg Virus Disease
Island Pharmaceuticals Ltd. (ILA.AX), an antiviral drug development and biodefence company, on Wednesday announced receipt of an orphan drug designation for Galidesivir in the post-exposure prophylaxis of Marburg virus disease from the U.S. Food and Drug …